Perspective

Revolutionizing Patient Safety: The Economic and Clinical

Impact of Artificial Intelligence in Hospitals
Francisco Epelde

Medicine Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT,
08208 Sabadell, Spain; fepelde@[Link]

Abstract: Artificial intelligence (AI) has emerged as a transformative force in enhancing patient
safety within hospital settings. This perspective explores the various applications of AI in improving
patient outcomes, including early warning systems, predictive analytics, process automation, and
personalized treatment. We also highlight the economic benefits associated with AI implementation,
such as cost savings through reduced adverse events and improved operational efficiency. Moreover,
the perspective addresses how AI can enhance pharmacological treatments, optimize diagnostic
testing, and mitigate hospital-acquired infections. Despite the promising advancements, challenges
related to data quality, ethical concerns, and clinical integration remain. Future research directions
are proposed to address these challenges and harness the full potential of AI in healthcare.

Keywords: artificial intelligence; patient safety; hospital management

1. Introduction
Ensuring patient safety is one of the foremost priorities in healthcare, particularly
within hospital settings, where the high-risk nature of complex care processes poses signifi-
cant challenges. Patients in hospitals frequently require coordinated and multidisciplinary
interventions, often involving various medications, medical devices, and diagnostic pro-
cedures that increase the potential for adverse events. In recent years, advancements in
Citation: Epelde, F. Revolutionizing
artificial intelligence (AI) have provided healthcare providers with new tools to reduce
Patient Safety: The Economic and
these risks by improving the monitoring, diagnosis, prediction, and management of patient
Clinical Impact of Artificial
conditions. By processing vast amounts of data, AI technologies such as machine learning
Intelligence in Hospitals. Hospitals
algorithms, predictive analytics, and natural language processing have the potential to
2024, 1, 185–194. [Link]
identify patterns and trends that are difficult to discern through traditional clinical methods.
10.3390/hospitals1020015
This perspective provides a comprehensive exploration of how AI applications contribute
Academic Editors: Jayasree (Joy) Basu to enhancing patient safety in healthcare environments, focusing on their clinical benefits,
and Mojtaba Vaismoradi economic advantages, and operational efficiency.
Received: 11 September 2024
The integration of AI in healthcare not only improves patient safety but also provides
Revised: 27 November 2024 economic benefits by reducing costs associated with adverse events, optimizing resource
Accepted: 3 December 2024 allocation, and increasing workflow efficiency. These financial savings are significant in
Published: 12 December 2024 a sector where cost pressures are increasing due to factors such as rising demand, con-
strained resources, and stringent regulatory requirements. However, as AI systems become
more embedded within clinical workflows, it is critical to address ethical and operational
challenges, such as data privacy, integration into clinical settings, and maintaining clin-
Copyright: © 2024 by the author. ical judgment alongside AI recommendations. This perspective will cover these issues,
Licensee MDPI, Basel, Switzerland.
exploring the opportunities and challenges posed by AI’s integration in healthcare.
This article is an open access article
distributed under the terms and 2. Applications of Artificial Intelligence in Patient Safety
conditions of the Creative Commons
2.1. Early Warning Systems
Attribution (CC BY) license (https://
[Link]/licenses/by/
AI-powered early warning systems (EWSs) have emerged as one of the most promis-
4.0/).
ing applications of AI in enhancing patient safety. These systems continuously monitor

Hospitals 2024, 1, 185–194. [Link] [Link]

Hospitals 2024, 1 186

patient data, including vital signs, laboratory results, and medication records, using so-
phisticated algorithms to detect early signs of patient deterioration. This is particularly
crucial for identifying life-threatening conditions such as sepsis, respiratory failure, and
cardiac arrest. The early detection and notification provided by EWSs allow healthcare pro-
fessionals to intervene more quickly, which has been shown to improve patient outcomes
significantly [1,2].
For example, AI-driven models for sepsis detection are now being implemented
in hospitals worldwide. Sepsis is a leading cause of mortality in intensive care units
(ICUs) and general wards alike, with outcomes heavily dependent on timely intervention.
Traditional methods of identifying sepsis rely on periodic monitoring of vital signs and
laboratory values, which can miss the early, subtle signs of the condition. AI-driven EWS
models, on the other hand, can detect early warning signs hours before clinical symptoms
become evident, enabling prompt intervention. Studies show that AI-based EWSs for sepsis
can reduce mortality rates significantly, lower ICU admissions, and reduce the length of
hospital stays [3,4]. The deployment of these systems has resulted in fewer critical incidents,
reinforcing their value as tools for proactive patient care [5,6].
Beyond sepsis, EWSs powered by AI can detect early signs of stroke, acute kidney
injury, and post-surgical complications, making these systems useful across various hospital
departments. In particular, AI models used in stroke care have demonstrated potential for
identifying minor signs of stroke from data patterns that are often missed by clinicians in
busy settings. This early intervention allows for the activation of stroke protocols and timely
treatment, which can significantly impact patient recovery and reduce disability rates.

2.2. Predictive Analytics

Predictive analytics, driven by AI algorithms, enables the anticipation of adverse
events and complications, which is essential for pre-emptive care planning. By analyz-
ing historical and real-time data, AI models can forecast the likelihood of complications
such as infections, organ failure, and bleeding, allowing clinicians to adjust care plans
accordingly. For example, predictive models in perioperative care are used to identify
patients at higher risk of developing acute respiratory distress syndrome (ARDS) following
surgery. This allows clinicians to allocate resources and implement preventive measures to
reduce the incidence and severity of ARDS, which is associated with high morbidity and
mortality [7,8].
In managing chronic diseases, predictive analytics has shown particular promise.
Chronic conditions such as diabetes, hypertension, and chronic obstructive pulmonary
disease (COPD) often lead to complications when patients are hospitalized. AI can help
monitor patients with these conditions by analyzing continuous data from wearables and
monitoring devices to detect instability in real time. For example, in diabetic patients,
predictive models can anticipate glycemic fluctuations, allowing providers to proactively
adjust insulin therapy or dietary recommendations. Similarly, predictive models for COPD
patients can help detect early signs of exacerbations, potentially preventing hospitalizations
through early outpatient interventions. By identifying high-risk patients, hospitals can
prioritize resources for those most in need and reduce avoidable admissions and ICU
utilization [9,10]. This capability not only improves patient outcomes but also offers sub-
stantial cost savings by reducing the frequency of emergency interventions and minimizing
ICU admissions [11,12].

2.3. Process Automation

AI-driven automation has made significant strides in healthcare, offering the potential
to improve safety, efficiency, and accuracy across a range of clinical processes. Automated
systems for medication administration, order processing, and documentation enhance
patient safety by reducing the likelihood of human errors. For instance, errors related
to medication administration—such as incorrect dosing, wrong timing, or administering
medications to the wrong patient—are a significant concern in hospitals. AI-driven sys-
Hospitals 2024, 1 187

tems can track medication administration in real time, cross-reference patient data, and
alert healthcare providers to potential issues, thereby reducing the risk of adverse drug
events [13,14].
One example of successful AI-driven automation is the use of smart IV infusion pumps,
which can precisely control the dosage of medications being delivered to patients, auto-
matically adjusting the infusion rate based on real-time monitoring. These systems have
proven effective in reducing dosage errors and minimizing risks associated with complex
medication regimens. Similarly, automated order entry systems reduce the likelihood of
transcription errors by allowing clinicians to input orders directly into the electronic health
record (EHR) system, which can be cross-checked for accuracy and potential contraindica-
tions using AI algorithms [15,16].
Automation also streamlines clinical documentation, which is often a time-consuming
task for healthcare providers. Automated documentation systems capture patient infor-
mation during clinical interactions, accurately recording it in the EHR without requiring
manual input. This allows clinicians to focus more on direct patient care, ultimately
improving efficiency and reducing the likelihood of documentation errors. Addition-
ally, automation can prioritize patient cases based on acuity, ensuring that high-risk pa-
tients receive timely care. AI-enabled triage systems are particularly beneficial in emer-
gency departments (EDs), where rapid and accurate triage is crucial for effective patient
management [17,18].

2.4. Personalized Treatment

One of AI’s most impactful contributions to patient safety is in the area of personalized
treatment. By analyzing vast amounts of patient data, including genetic, demographic, and
clinical information, AI models can identify unique patient characteristics that influence
treatment responses. This allows healthcare providers to tailor interventions to individual
needs, reducing the risks of adverse drug reactions and ineffective treatments. For instance,
pharmacogenomic AI models can help determine optimal drug dosages by analyzing a
patient’s genetic profile, minimizing the risk of over- or under-dosing and reducing the
likelihood of adverse drug reactions [19,20].
Personalized treatment is not limited to medication dosing. AI is being used in
oncology to customize chemotherapy regimens based on genetic markers that indicate
how specific tumor types will respond to various therapies. This precision helps reduce
toxicity and enhance the efficacy of cancer treatments, improving patient outcomes and
minimizing treatment-related complications [21,22]. AI also plays a significant role in
tailoring interventions for patients with mental health disorders by analyzing a patient’s
clinical history, genetic background, and lifestyle factors to develop personalized treatment
plans that optimize therapeutic outcomes. This approach helps avoid the trial-and-error
process commonly associated with mental health treatment, thus improving adherence and
reducing hospital readmissions [23,24].

3. Economic Benefits of AI in Patient Safety

3.1. Cost Savings from Reduced Adverse Events
One of the most significant financial impacts of AI in healthcare is its potential to
reduce costs by preventing adverse events. Severe adverse events, such as sepsis, organ
failure, or hospital-acquired infections (HAIs), often require extensive resources and can
lead to prolonged ICU stays, increasing treatment costs substantially. By detecting risks
early, AI helps prevent the escalation of these conditions, reducing the need for expensive
interventions [25,26]. For instance, AI models used in sepsis prediction have shown
the potential to reduce costs associated with ICU admissions and long hospital stays by
enabling early intervention. Studies indicate that hospitals implementing AI-driven EWSs
for sepsis detection experience lower healthcare costs due to fewer ICU admissions and
shorter patient stays, as well as a reduction in the use of high-cost interventions [27,28].
Hospitals 2024, 1 188

AI also mitigates legal liabilities associated with adverse events, as hospitals can
demonstrate that they have implemented advanced safety systems to monitor patients
continuously. Preventing critical incidents not only enhances patient safety but also lowers
potential legal costs associated with malpractice cases, a significant concern in high-risk
hospital environments.

3.2. Improved Operational Efficiency

AI contributes to operational efficiency by automating routine tasks, supporting data-
driven decision-making, and optimizing resource allocation. By reducing the amount of
time healthcare providers spend on repetitive tasks such as data entry, scheduling, and
documentation, AI systems free up more time for direct patient care, thereby improving
productivity and reducing labor costs [29,30]. Automation tools, such as AI-driven billing
and coding systems, streamline administrative processes by ensuring accurate documenta-
tion and compliance with billing regulations. This results in faster claim processing, fewer
denied claims, and overall reduction in administrative costs.
AI also supports optimized resource management through predictive analytics that
anticipate high-demand periods and adjust staffing levels accordingly. For example, in
emergency departments, predictive models forecast patient inflow and assist in scheduling
staff during peak times to ensure adequate coverage. These efficiencies enhance patient
satisfaction by reducing wait times, improving service quality, and ensuring that clinicians
are not overburdened during high-demand periods [31,32].

3.3. Enhanced Resource Utilization

Optimizing resource utilization is essential for maintaining cost-effective operations
in healthcare settings. AI assists hospitals in efficiently utilizing resources by predicting
patient needs, managing bed occupancy, and forecasting staffing requirements. Predictive
analytics models enable hospitals to allocate resources more precisely, such as ensuring
that beds are available for patients at high risk of ICU transfer. Additionally, AI-driven
resource management systems provide insights into supply chain requirements, allowing
hospitals to maintain optimal stock levels of medications, personal protective equipment,
and medical devices. This just-in-time approach to resource management reduces waste
and prevents supply shortages that could impact patient care [33,34].
Moreover, AI systems enhance resource utilization by identifying patients who may
benefit from alternative care settings, such as outpatient care or home health services, rather
than inpatient hospitalization. For instance, AI can analyze a patient’s risk profile and
recommend the most appropriate post-discharge plan, reducing readmission rates and
optimizing bed capacity for new admissions. This efficient allocation of resources supports
overall patient safety and reduces operational costs [35,36].

4. Impact on Pharmacological Treatments, Diagnostic Testing, and Nosocomial Infections

4.1. Pharmacological Treatments
AI plays a transformative role in optimizing pharmacological treatments, particularly
by enabling personalized dosing and reducing the risk of adverse drug reactions. Pharma-
cogenomics, the study of how genes affect a person’s response to drugs, has increasingly
become integrated with AI technology to tailor drug prescriptions based on genetic profiles.
This approach allows AI to provide clinicians with insights into optimal medication types,
dosages, and potential interactions specific to each patient [37,38]. Traditional methods
of determining medication dosage are largely based on population averages and may not
always align with individual patient needs, increasing the risk of adverse reactions or
ineffective treatment.
With AI, real-time data analysis can track how individual patients metabolize drugs,
alerting clinicians if a patient is at risk of an adverse reaction based on metabolic speed
or interaction with other medications. This precision has proven especially valuable in
oncology, where patients undergoing chemotherapy benefit from targeted dosing that
Hospitals 2024, 1 189

minimizes toxicity while maximizing therapeutic effects [39,40]. AI’s role in personalized
medication has also proven crucial in mental health treatment, where AI-driven systems
analyze patient data to predict likely responses to antidepressants and antipsychotics,
reducing the trial-and-error process that often accompanies treatment adjustments.

4.2. Diagnostic Testing

Diagnostic testing is another domain where AI-driven solutions significantly enhance
patient safety. AI algorithms, particularly machine learning models, can analyze complex
diagnostic images and identify abnormalities with accuracy comparable to, or sometimes
even exceeding, that of human specialists. For instance, AI applications in radiology
use image recognition algorithms to detect signs of lung nodules, bone fractures, and
cardiovascular anomalies from X-rays, CT scans, and MRIs. The implementation of AI
in diagnostic imaging not only improves accuracy but also reduces the time required to
interpret results, allowing for faster diagnosis and intervention [41,42].
One of the major benefits of AI in diagnostics is its ability to catch early signs of
diseases that might otherwise be overlooked in initial reviews, especially in high-pressure
settings such as emergency departments. AI systems in radiology can highlight areas of
interest in images, drawing the attention of radiologists to potential abnormalities that
require further investigation. For example, in mammography, AI models are being used
to detect early-stage breast cancer, with studies showing that these models can reduce
false negatives and improve the early detection rates of cancers that are more challenging
to detect [43,44]. Such advancements ultimately lead to timely treatments, reducing the
need for more extensive interventions that would have been necessary had the disease
progressed further.

4.3. Nosocomial Infections

Nosocomial infections, or hospital-acquired infections (HAIs), pose a significant risk
to patient safety, especially in ICUs and surgical units where patients are vulnerable to
infections due to compromised immunity or invasive procedures. AI-driven systems help
prevent and manage HAIs by analyzing patient data and identifying those at elevated
risk. For instance, predictive models can assess risk factors for infections like pneumonia,
surgical site infections, and Clostridioides difficile infections, providing alerts to clinicians
when intervention is needed. By enabling early detection, these models help mitigate the
spread of infections and reduce associated healthcare costs [45,46].
AI has also contributed to infection control through its role in antimicrobial steward-
ship. In hospitals, overuse of antibiotics is a common issue, often resulting in antibiotic
resistance. AI models analyze data on infection trends, patient demographics, and pathogen
resistance profiles, guiding appropriate antibiotic use. This targeted approach to antibiotic
prescription has proven effective in reducing cases of antimicrobial resistance, improving
patient outcomes, and ultimately curbing healthcare costs [47,48]. Moreover, AI tools moni-
tor compliance with infection control measures such as hand hygiene, room sanitation, and
equipment sterilization. This automated monitoring ensures that infection control protocols
are adhered to consistently, thereby reducing HAIs and enhancing overall patient safety.

5. Challenges and Limitations

While the benefits of AI in healthcare are substantial, the technology also faces several
challenges and limitations that impact its full integration and effectiveness.

5.1. Data Quality and Availability

The effectiveness of AI in healthcare largely depends on the availability of high-quality,
comprehensive data. Inaccurate or incomplete data can lead to erroneous predictions and
unreliable decision-making, which may compromise patient safety. Many healthcare
organizations still face challenges related to data standardization, interoperability, and data
entry errors, limiting the utility of AI tools. The lack of integrated data systems across
Hospitals 2024, 1 190

departments and institutions further complicates the deployment of AI solutions, as these

systems often rely on information from multiple sources to make accurate predictions
and recommendations [49,50]. To maximize the effectiveness of AI, healthcare providers
must invest in standardized data collection and integration practices that ensure data
completeness and accuracy [51,52].

5.2. Ethical and Privacy Concerns

AI applications in healthcare rely heavily on the use of sensitive patient data, raising
significant ethical and privacy concerns. Patient data must be handled with utmost care
to protect confidentiality, ensure compliance with regulations, and maintain public trust.
In many cases, data used for AI training purposes are subject to strict regulatory controls,
particularly with laws like the Health Insurance Portability and Accountability Act (HIPAA)
in the United States, which mandate the secure handling of patient information [53,54]. To
address these challenges, healthcare organizations must establish robust data protection
frameworks, and AI developers should prioritize transparency in their algorithms to avoid
potential biases and ethical dilemmas associated with automated decision-making [55,56].

5.3. Clinical Integration and Acceptance

The integration of AI into clinical workflows is another major challenge, as healthcare
professionals may resist adopting new technologies without sufficient training or evidence
of value. Successful implementation of AI systems requires a comprehensive approach to
change management, including training programs that highlight the practical benefits of AI
tools. Healthcare providers must feel confident that AI will not replace their expertise but
will serve as an adjunct to enhance their decision-making capabilities [57,58]. Furthermore,
demonstrating the efficacy of AI tools through clinical trials and studies is essential in
increasing acceptance among healthcare professionals.

5.4. Dependence and Error Risks

The risk of over-reliance on AI systems is a concern, as it could lead to diminished
clinical judgment and potential patient harm if an AI system fails or provides inaccurate
information. AI models, particularly those based on machine learning, are susceptible to
errors due to the limitations of their training data or unintended biases within the algo-
rithms. Healthcare providers must strike a balance between utilizing AI recommendations
and exercising clinical judgment. Maintaining human oversight and establishing protocols
for verifying AI-generated recommendations are crucial steps for minimizing risk and
ensuring effective patient care [59,60].

6. Conclusions
Artificial intelligence offers substantial benefits in healthcare, particularly in enhancing
patient safety by improving monitoring, predictive capabilities, and personalized treatment
approaches. The economic advantages associated with AI, such as reduced adverse events,
increased operational efficiency, and optimized resource utilization, underscore its potential
impact on modern healthcare systems. AI’s role in optimizing pharmacological treatments,
refining diagnostic testing, and controlling nosocomial infections further highlights its
value. Nevertheless, challenges related to data quality, ethical concerns, and clinical
integration must be addressed to maximize AI’s potential.
For AI to fulfill its promise in healthcare, ongoing research, collaboration, and commit-
ment to ethical standards are essential. Implementing policies that protect patient privacy,
ensure data accuracy, and support clinical training will pave the way for responsible AI
integration. As healthcare continues to evolve with the adoption of AI, the potential to en-
hance patient safety and improve clinical outcomes will increase, benefiting both healthcare
providers and patients alike.
Hospitals 2024, 1 191

7. Future Directions
Future research should focus on the following areas to further advance the integration
of AI in healthcare:

7.1. Enhancing Data Quality and Interoperability

To maximize the potential of AI in healthcare, there is a pressing need to develop
standardized methods for data collection, ensuring accuracy and consistency across diverse
health systems. Research should focus on creating interoperable data-sharing frameworks
that facilitate seamless integration across different healthcare platforms and systems. Inter-
operable data can improve the accuracy of AI models by providing access to comprehensive
datasets, thus enabling more reliable predictions and recommendations [61,62].

7.2. Addressing Ethical and Privacy Issues

Establishing clear guidelines for AI ethics and privacy is essential for the responsible
implementation of AI in healthcare. Researchers and policymakers must collaborate to
create policies that ensure patient data are handled with care, protecting confidentiality
and preventing potential biases in AI algorithms. Future work should explore methods for
algorithm transparency, enabling healthcare providers to understand and verify AI-driven
decisions in patient care [63,64].

7.3. Facilitating Clinical Adoption

Clinical adoption of AI requires extensive training and education for healthcare
providers. Future research should focus on developing training programs that demonstrate
the value of AI tools and improve healthcare professionals’ understanding of AI technology.
These programs should emphasize that AI serves as a support tool, enhancing clinical
decision-making rather than replacing it. Practical, evidence-based demonstrations of AI’s
effectiveness in real-world clinical scenarios will also be key to fostering acceptance and
utilization [65,66].

7.4. Longitudinal Impact Studies

Long-term studies are needed to assess the impact of AI on patient safety, clinical
outcomes, and healthcare costs. These studies should investigate the effects of AI on
various patient populations, care settings, and health conditions to determine where AI
interventions are most beneficial. Longitudinal impact studies will also provide insights
into potential unintended consequences of AI deployment, helping healthcare providers
make informed decisions regarding the use of AI technologies [67,68].

Funding: This research received no external funding.

Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Conflicts of Interest: The author declares no conflicts of interest.

References
1. Yang, J.; Hao, S.; Huang, J.; Chen, T.; Liu, R.; Zhang, P.; Feng, M.; He, Y.; Xiao, W.; Hong, Y.; et al. The application of artificial
intelligence in the management of sepsis. Med. Rev. 2023, 3, 369–380. [CrossRef] [PubMed]
2. Muralitharan, S.; Nelson, W.; Di, S.; McGillion, M.; Devereaux, P.J.; Barr, N.G.; Petch, J. Machine Learning-Based Early Warning
Systems for Clinical Deterioration: Systematic Scoping Review. J. Med. Internet Res. 2021, 23, e25187. [CrossRef] [PubMed]
[PubMed Central]
3. Lim, L.; Gim, U.; Cho, K.; Yoo, D.; Ryu, H.G.; Lee, H.C. Real-time machine learning model to predict short-term mortality in
critically ill patients: Development and international validation. Crit. Care 2024, 28, 76. [CrossRef] [PubMed]
4. Meckawy, R.; Stuckler, D.; Mehta, A.; Al-Ahdal, T.; Doebbeling, B.N. Effectiveness of early warning systems in the detection of
infectious diseases outbreaks: A systematic review. BMC Public Health 2022, 22, 2216. [CrossRef] [PubMed] [PubMed Central]
5. Veldhuis, L.I.; Woittiez, N.J.C.; Nanayakkara, P.W.B.; Ludikhuize, J. Artificial Intelligence for the Prediction of In-Hospital Clinical
Deterioration: A Systematic Review. Crit. Care Explor. 2022, 4, e0744. [CrossRef] [PubMed] [PubMed Central]
Hospitals 2024, 1 192

6. Huang, Y.; Talwar, A.; Chatterjee, S.; Aparasu, R.R. Application of machine learning in predicting hospital readmissions: A
scoping review of the literature. BMC Med. Res. Methodol. 2021, 21, 96. [CrossRef] [PubMed] [PubMed Central]
7. Zhang, Z. Predictive analytics in the era of big data: Opportunities and challenges. Ann. Transl. Med. 2020, 8, 68. [CrossRef]
[PubMed] [PubMed Central]
8. Davis, S.; Zhang, J.; Lee, I.; Rezaei, M.; Greiner, R.; McAlister, F.A.; Padwal, R. Effective hospital readmission prediction models
using machine-learned features. BMC Health Serv Res 2022, 22, 1415. [CrossRef]
9. Wu, Y.; Li, L.; Xin, B.; Hu, Q.; Dong, X.; Li, Z. Application of machine learning in personalized medicine. Intell. Pharm. 2023, 1,
152–156. [CrossRef]
10. Johnson, K.B.; Wei, W.Q.; Weeraratne, D.; Frisse, M.E.; Misulis, K.; Rhee, K.; Zhao, J.; Snowdon, J.L. Precision Medicine, AI, and
the Future of Personalized Health Care. Clin. Transl. Sci. 2021, 14, 86–93. [CrossRef] [PubMed] [PubMed Central]
11. Aoun, M.; Sandhu, A.K. Understanding the Impact of AI-Driven Automation on the Workflow of Radiologists in Emergency Care
Settings. J. Intell. Connect. Emerg. Technol. 2019, 4, 1–15. Available online: [Link]
article/view/11 (accessed on 1 December 2024).
12. Dubey, K.; Bhowmik, M.; Pawar, A.; Patil, M.K.; Deshpande, P.A.; Khartad, S.S. Enhancing Operational Efficiency in Healthcare
with AI-Powered Management. In Proceedings of the 2023 International Conference on Artificial Intelligence for Innovations in
Healthcare Industries (ICAIIHI), Raipur, India, 29–30 December 2023; pp. 1–7. [CrossRef]
13. Johnson, A.; Pollard, T.; Shen, L.; Lehman, L.-W.H.; Feng, M.; Ghassemi, M.; Moody, B.; Szolovits, P.; Celi, L.A.; Mark, R.G.
MIMIC-III, a freely accessible critical care database. Sci. Data 2016, 3, 160035. [CrossRef] [PubMed]
14. Alowais, S.A.; Alghamdi, S.S.; Alsuhebany, N.; Alqahtani, T.; Alshaya, A.I.; Almohareb, S.N.; Aldairem, A.; Alrashed, M.; Bin
Saleh, K.; Badreldin, H.A.; et al. Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Med. Educ.
2023, 23, 689. [CrossRef] [PubMed]
15. Naik, K.; Goyal, R.K.; Foschini, L.; Chak, C.W.; Thielscher, C.; Zhu, H.; Lu, J.; Lehár, J.; Pacanoswki, M.A.; Terranova, N.; et al.
Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine. Clin.
Pharmacol. Ther. 2024, 115, 673–686. [CrossRef]
16. MacEachern, S.J.; Forkert, N.D. Machine learning for precision medicine. Genome 2021, 64, 416–425. [CrossRef] [PubMed]
17. Singareddy, S.; Sn, V.P.; Jaramillo, A.P.; Yasir, M.; Iyer, N.; Hussein, S.; Nath, T.S. Artificial Intelligence and Its Role in the
Management of Chronic Medical Conditions: A Systematic Review. Cureus 2023, 15, e46066. [CrossRef] [PubMed] [PubMed
Central]
18. Byrne, D.W.; Domenico, H.J.; Moore, R.P. Artificial Intelligence for Improved Patient Outcomes-The Pragmatic Randomized
Controlled Trial Is the Secret Sauce. Korean J. Radiol. 2024, 25, 123–125. [CrossRef] [PubMed] [PubMed Central]
19. Crisafulli, S.; Ciccimarra, F.; Bellitto, C.; Carollo, M.; Carrara, E.; Stagi, L.; Triola, R.; Capuano, A.; Chiamulera, C.; Moretti, U.; et al.
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: Challenges and opportunities.
Front. Drug Saf. Regul. 2024, 4, 1356405. [CrossRef]
20. Najjar, R. Redefining Radiology: A Review of Artificial Intelligence Integration in Medical Imaging. Diagnostics 2023, 13, 2760.
[CrossRef] [PubMed] [PubMed Central]
21. Radaelli, D.; Di Maria, S.; Jakovski, Z.; Alempijevic, D.; Al-Habash, I.; Concato, M.; Bolcato, M.; D’Errico, S. Advancing Patient
Safety: The Future of Artificial Intelligence in Mitigating Healthcare-Associated Infections: A Systematic Review. Healthcare 2024,
12, 1996. [CrossRef]
22. Arzilli, G.; De Vita, E.; Pasquale, M.; Carloni, L.M.; Pellegrini, M.; Di Giacomo, M.; Esposito, E.; Porretta, A.D.; Rizzo, C.
Innovative Techniques for Infection Control and Surveillance in Hospital Settings and Long-Term Care Facilities: A Scoping
Review. Antibiotics 2024, 13, 77. [CrossRef] [PubMed] [PubMed Central]
23. Yang, L.; Lu, S.; Zhou, L. The Implications of Artificial Intelligence on Infection Prevention and Control: Current Progress and
Future Perspectives. China CDC Wkly. 2024, 6, 901–904. [CrossRef] [PubMed] [PubMed Central]
24. Nguemeleu, E.T.; Beogo, I.; Sia, D.; Kilpatrick, K.; Séguin, C.; Baillot, A.; Jabbour, M.; Parisien, N.; Robins, S.; Boivin, S. Economic
analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review
using a discounting approach. J. Hosp. Infect. 2020, 106, 134–154. [CrossRef] [PubMed] [PubMed Central]
25. Bates, D.W.; Levine, D.; Syrowatka, A.; Kuznetsova, M.; Craig, K.J.T.; Rui, A.; Jackson, G.P.; Rhee, K. The potential of artificial
intelligence to improve patient safety: A scoping review. NPJ Digit. Med. 2021, 4, 54. [CrossRef] [PubMed] [PubMed Central]
26. Zwerwer, L.R.; van der Pol, S.; Zacharowski, K.; Postma, M.J.; Kloka, J.; Friedrichson, B.; van Asselt, A.D.I. The value of artificial
intelligence for the treatment of mechanically ventilated intensive care unit patients: An early health technology assessment. J.
Crit. Care 2024, 82, 154802. [CrossRef] [PubMed]
27. Khanna, N.N.; Maindarkar, M.A.; Viswanathan, V.; Fernandes, J.F.E.; Paul, S.; Bhagawati, M.; Ahluwalia, P.; Ruzsa, Z.; Sharma, A.;
Kolluri, R.; et al. Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment. Healthcare 2022, 10, 2493. [CrossRef]
[PubMed] [PubMed Central]
28. Khosravi, M.; Zare, Z.; Mojtabaeian, S.M.; Izadi, R. Artificial Intelligence and Decision-Making in Healthcare: A Thematic
Analysis of a Systematic Review of Reviews. Health Serv. Res. Manag. Epidemiol. 2024, 11, 23333928241234863. [CrossRef]
[PubMed] [PubMed Central]
29. Ramezani, M.; Takian, A.; Bakhtiari, A.; Rabiee, H.R.; Fazaeli, A.A.; Sazgarnejad, S. The application of artificial intelligence in
health financing: A scoping review. Cost Eff. Resour. Alloc. 2023, 21, 83. [CrossRef]
Hospitals 2024, 1 193

30. Davenport, T.; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J. 2019, 6, 94–98. [CrossRef]
[PubMed] [PubMed Central]
31. Rahimi, A.K.; Pienaar, O.; Ghadimi, M.; Canfell, O.J.; Pole, J.D.; Shrapnel, S.; van der Vegt, A.H.; Sullivan, C. Implementing AI in
Hospitals to Achieve a Learning Health System: Systematic Review of Current Enablers and Barriers. J. Med. Internet Res. 2024,
26, e49655. [CrossRef] [PubMed] [PubMed Central]
32. Bhagat, S.V.; Kanyal, D. Navigating the Future: The Transformative Impact of Artificial Intelligence on Hospital Management—A
Comprehensive Review. Cureus 2024, 16, e54518. [CrossRef] [PubMed] [PubMed Central]
33. Ebugosi, Q.-M.; Olaboye, J. Optimizing healthcare resource allocation through data-driven demographic and psychographic
analysis. Comput. Sci. IT Res. J. 2024, 5, 1488–1504. [CrossRef]
34. Sheng, J.Q.; Hu, P.J.; Liu, X.; Huang, T.S.; Chen, Y.H. Predictive Analytics for Care and Management of Patients with Acute
Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes. J. Med. Internet Res. 2021, 23, e18372.
[CrossRef] [PubMed] [PubMed Central]
35. Lindroth, H.; Nalaie, K.; Raghu, R.; Ayala, I.N.; Busch, C.; Bhattacharyya, A.; Franco, P.M.; Diedrich, D.A.; Pickering, B.W.;
Herasevich, V. Applied Artificial Intelligence in Healthcare: A Review of Computer Vision Technology Application in Hospital
Settings. J. Imaging 2024, 10, 81. [CrossRef]
36. Francis, J.; Varghese, J.; Thomas, A. Impact of artificial intelligence on healthcare. Int. J. Adv. Med. 2023, 10, 10. [CrossRef]
37. Vora, L.K.; Gholap, A.D.; Jetha, K.; Thakur, R.R.S.; Solanki, H.K.; Chavda, V.P. Artificial Intelligence in Pharmaceutical Technology
and Drug Delivery Design. Pharmaceutics 2023, 15, 1916. [CrossRef] [PubMed] [PubMed Central]
38. Ali, K.A.; Mohin, S.; Mondal, P.; Goswami, S.; Ghosh, S.; Choudhuri, S. Influence of artificial intelligence in modern pharmaceutical
formulation and drug development. Future J. Pharm. Sci. 2024, 10, 53. [CrossRef]
39. Danysz, K.; Cicirello, S.; Mingle, E.; Assuncao, B.; Tetarenko, N.; Mockute, R.; Abatemarco, D.; Widdowson, M.; Desai, S. Artificial
Intelligence and the Future of the Drug Safety Professional. Drug Saf. 2019, 42, 491–497. [CrossRef] [PubMed] [PubMed Central]
40. Carini, C.; Seyhan, A.A. Tribulations and future opportunities for artificial intelligence in precision medicine. J. Transl. Med. 2024,
22, 411. [CrossRef]
41. Meşe, İ.; Taşlıçay, C.A.; Kuzan, B.N.; Kuzan, T.Y.; Sivrioğlu, A.K. Educating the next generation of radiologists: A comparative
report of ChatGPT and e-learning resources. Diagn. Interv. Radiol. 2024, 30, 163–174. [CrossRef]
42. Brady, A.P.; Allen, B.; Chong, J.; Kotter, E.; Kottler, N.; Mongan, J.; Oakden-Rayner, L.; dos Santos, D.P.; Tang, A.; Wald, C.; et al.
Developing, purchasing, implementing and monitoring AI tools in radiology: Practical considerations. A multi-society statement
from the ACR, CAR, ESR, RANZCR & RSNA. Insights Imaging 2024, 15, 16. [CrossRef] [PubMed]
43. Ouanes, K.; Farhah, N. Effectiveness of Artificial Intelligence (AI) in Clinical Decision Support Systems and Care Delivery. J. Med.
Syst. 2024, 48, 74. [CrossRef] [PubMed]
44. Wang, H.; Jia, S.; Li, Z.; Duan, Y.; Tao, G.; Zhao, Z. A Comprehensive Review of Artificial Intelligence in Prevention and Treatment
of COVID-19 Pandemic. Front. Genet. 2022, 13, 845305. [CrossRef] [PubMed] [PubMed Central]
45. Baddal, B.; Taner, F.; Ozsahin, D.U. Harnessing of Artificial Intelligence for the Diagnosis and Prevention of Hospital-Acquired
Infections: A Systematic Review. Diagnostics 2024, 14, 484. [CrossRef] [PubMed] [PubMed Central]
46. Zhang, X.; Zhang, D.; Zhang, X.; Zhang, X. Artificial intelligence applications in the diagnosis and treatment of bacterial infections.
Front. Microbiol. 2024, 15, 1449844. [CrossRef] [PubMed] [PubMed Central]
47. Blatnik, P.; Bojnec, Š. Analysis of impact of nosocomial infections on cost of patient hospitalisation. Cent. Eur. J. Public Health 2023,
31, 90–96. [CrossRef] [PubMed]
48. Ranjbar, A.; Ravn, J. Data Quality in Healthcare for the Purpose of Artificial Intelligence: A Case Study on ECG Digitalization.
Stud. Health Technol. Inform. 2023, 305, 471–474. [CrossRef] [PubMed]
49. Klooster, I.T.; Kip, H.; van Gemert-Pijnen, L.; Crutzen, R.; Kelders, S. A systematic review on eHealth technology personalization
approaches. iScience 2024, 27, 110771. [CrossRef] [PubMed] [PubMed Central]
50. Karalis, V.D. The Integration of Artificial Intelligence into Clinical Practice. Appl. Biosci. 2024, 3, 14–44. [CrossRef]
51. Petersson, L.; Larsson, I.; Nygren, J.M.; Nilsen, P.; Neher, M.; Reed, J.E.; Tyskbo, D.; Svedberg, P. Challenges to implementing
artificial intelligence in healthcare: A qualitative interview study with healthcare leaders in Sweden. BMC Health Serv. Res. 2022,
22, 850. [CrossRef]
52. Kolluri, V. Ethical Considerations in the Use of AI in Healthcare: Discussing the Ethical Dilemmas and Considerations of
Implementing AI in Patient Care and Decision-Making Venkateswaranaidu Kolluri. J. Emerg. Technol. Innov. Res. 2024, 11,
i330–i335.
53. Murdoch, B. Privacy and artificial intelligence: Challenges for protecting health information in a new era. BMC Med. Ethics 2021,
22, 122. [CrossRef] [PubMed]
54. MacIntyre, M.R.; Cockerill, R.G.; Mirza, O.F.; Appel, J.M. Ethical considerations for the use of artificial intelligence in medical
decision-making capacity assessments. Psychiatry Res. 2023, 328, 115466. [CrossRef] [PubMed]
55. Abujaber, A.A.; Nashwan, A.J. Ethical framework for artificial intelligence in healthcare research: A path to integrity. World J.
Methodol. 2024, 14, 94071. [CrossRef] [PubMed] [PubMed Central]
56. Macri, R.; Roberts, S.L. The Use of Artificial Intelligence in Clinical Care: A Values-Based Guide for Shared Decision Making.
Curr. Oncol. 2023, 30, 2178–2186. [CrossRef] [PubMed] [PubMed Central]
Hospitals 2024, 1 194

57. Ranjbar, A.; Mork, E.W.; Ravn, J.; Brøgger, H.; Myrseth, P.; Østrem, H.P.; Hallock, H. Managing Risk and Quality of AI in
Healthcare: Are Hospitals Ready for Implementation? Risk Manag. Healthc. Policy 2024, 17, 877–882. [CrossRef] [PubMed]
[PubMed Central]
58. Choudhury, A.; Asan, O. Role of Artificial Intelligence in Patient Safety Outcomes: Systematic Literature Review. JMIR Med.
Inform. 2020, 8, e18599. [CrossRef] [PubMed] [PubMed Central]
59. Bajwa, J.; Munir, U.; Nori, A.; Williams, B. Artificial intelligence in healthcare: Transforming the practice of medicine. Future
Healthc. J. 2021, 8, e188–e194. [CrossRef] [PubMed] [PubMed Central]
60. Aldoseri, A.; Al-Khalifa, K.N.; Hamouda, A.M. Re-Thinking Data Strategy and Integration for Artificial Intelligence: Concepts,
Opportunities, and Challenges. Appl. Sci. 2023, 13, 7082. [CrossRef]
61. Gerke, S.; Minssen, T.; Cohen, G. Ethical and legal challenges of artificial intelligence-driven healthcare. In Artificial Intelligence in
Healthcare; Elsevier: Amsterdam, The Netherlands, 2020; pp. 295–336. [CrossRef] [PubMed Central]
62. Yim, D.; Khuntia, J.; Parameswaran, V.; Meyers, A. Preliminary Evidence of the Use of Generative AI in Health Care Clinical
Services: Systematic Narrative Review. JMIR Med. Inform. 2024, 12, e52073. [CrossRef] [PubMed] [PubMed Central]
63. Charow, R.; Jeyakumar, T.; Younus, S.; Dolatabadi, E.; Salhia, M.; Al-Mouaswas, D.; Anderson, M.; Balakumar, S.; Clare, M.;
Dhalla, A.; et al. Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review. JMIR Med. Educ. 2021,
7, e31043. [CrossRef] [PubMed] [PubMed Central]
64. Mukherjee, J.; Sharma, R.; Dutta, P.; Bhunia, B. Artificial intelligence in healthcare: A mastery. Biotechnol Genet Eng Rev. 2024, 40,
1659–1708. [CrossRef] [PubMed]
65. Al Meslamani, A.Z. Beyond implementation: The long-term economic impact of AI in healthcare. J. Med. Econ. 2023, 26, 1566–1569.
[CrossRef] [PubMed]
66. Epelde, F. Optimizing Cardiac Rehabilitation in Heart Failure: Comprehensive Insights, Barriers, and Future Strategies. Medicina
2024, 60, 1583. [CrossRef] [PubMed] [PubMed Central]
67. Caldwell, H.A.T.; Yusuf, J.; Carrea, C.; Conrad, P.; Embrett, M.; Fierlbeck, K.; Hajizadeh, M.; Kirk, S.F.L.; Rothfus, M.; Sampalli,
T.; et al. Strategies and indicators to integrate health equity in health service and delivery systems in high-income countries: A
scoping review. JBI Evid. Synth. 2024, 22, 949–1070. [CrossRef] [PubMed] [PubMed Central]
68. Nadarzynski, T.; Knights, N.; Husbands, D.; Graham, C.A.; Llewellyn, C.D.; Buchanan, T.; Montgomery, I.; Ridge, D. Achieving
health equity through conversational AI: A roadmap for design and implementation of inclusive chatbots in healthcare. PLoS
Digit. Health 2024, 3, e0000492. [CrossRef] [PubMed] [PubMed Central]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.